- Madrigal Pharmaceuticals (NASDAQ:MDGL): Q3 GAAP EPS of -$1.39 in-line.
- Cash, cash equivalents and marketable securities of $453.6M
- Press Release
Madrigal Pharmaceuticals EPS in-line
Recommended For You
More Trending News
About MDGL Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
MDGL | - | - |
Madrigal Pharmaceuticals, Inc. |